Overview

Gender

male

Jim is a co-founder, President and director of BC Advantage Funds (VCC) Ltd. BC Advantage is a venture fund that invests in, and builds, successful technology, life science and clean technology companies.

Jim has a Bachelor of Science degree in Microbiology and a law degree from the University of British Columbia. After being called to the Bar, he worked for six years with Fasken Martineau DuMoulin, during which time he was seconded to the BC Securities Commission for six months. Jim then became President and Chief Executive Officer of Catalyst Corporate Finance Lawyers, a boutique corporate finance law firm that focused on assisting life science and technology companies. He is a past member of the Securities Policy Advisory Committee to the BCSC and is a Past-Chairman of the Securities Section of the Canadian Bar Association (B.C. Branch).

During his career, Jim has participated in building a number of successful companies, including, Aspreva Pharmaceuticals (acquired by Galenica Ltd.), Immgenics (acquired by Abgenix, Inc.), Endurance Wind Power, OncoGenex Pharmaceuticals (NASDAQ: OGXI), Sophiris Bio Inc. (TSX: SHS), Tekmira Pharmaceuticals (TSX: TKM) and Methylation Sciences. Jim is currently a director of a number of public and private technology and life science companies.

Over the years, Jim has written a number of articles and coordinated and taught numerous courses on corporate finance and corporate governance issues. The Vancouver Sun has recognized Jim as one of the top 15 "Up and Comers" in British Columbia.